SIS3,
521984-48-5,
Sis3 HCl,
MFCD09265258,
(2E)-1-(6,7-Dimethoxy-3,4-dihydro-1H-isoquinolin-2-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-propenone hydrochloride,
SIS-3,
Caneritinib,
SIS3(HCl),
SCHEMBL6488320,
SCHEMBL6488325,
CANERITINIB(CI-1033),
CHEBI:87461,
AOB5022,
BCP19304,
EX-A1151,
s7959,
AKOS025147342,
SIS3, >=98% (HPLC), powder,
CS-5768,
ACM521984485,
HY-13013,
RT-015709,
(2E)-1-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one hydrochloride,
(E)-1-(6,7-dimethoxy-3,4-dihydroisoquinolin-2(1H)-yl)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)prop-2-en-1-one HCl,
1,2,3,4-Tetrahydro-6,7-dimethoxy-2-[(2E)-3-(1-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-oxo-2-propenyl]-isoquinoline hydrochloride,
isoquinoline, 1,2,3,4-tetrahydro-6,7-dimethoxy-2-[(2E)-3-(1-methyl-2-phenyl-1H-pyrrolo[2,3-b]pyridin-3-yl)-1-oxo-2-propenyl]-, monohydrochloride,
SIS3 hydrochloride,
Smad3 Inhibitor, SIS3,
Specific Inhibitor of Smad3,
CI-1033,
A16065,